Cargando…
Rifaximin is an effective alternative to metronidazole for the treatment of chronic enteropathy in dogs: a randomised trial
BACKGROUND: A clinical trial was conducted in order to assess the efficacy of rifaximin, a broad-spectrum antibiotic with negligible gastrointestinal absorption, in comparison with metronidazole, a commonly employed antimicrobial drug, in dogs with chronic enteropathy. Twenty-four pet dogs were rand...
Autores principales: | Menozzi, Alessandro, Dall’Aglio, Manuel, Quintavalla, Fausto, Dallavalle, Luca, Meucci, Valentina, Bertini, Simone |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5053129/ https://www.ncbi.nlm.nih.gov/pubmed/27716258 http://dx.doi.org/10.1186/s12917-016-0851-0 |
Ejemplares similares
-
Cystoscopic Guided Laser Cauterization in a Dog with Complete Y-Type Urethral Duplication
por: Dall’Aglio, Manuel, et al.
Publicado: (2023) -
Microbial Isolates from Vegetable Foreign Bodies Inhaled by Dogs
por: Flisi, Sara, et al.
Publicado: (2018) -
Rifaximin Therapy for Patients With Metronidazole-Unresponsive Clostridium difficile Infection
por: Waqas, Muhammad, et al.
Publicado: (2022) -
Therapeutic Success of Rifaximin for Clostridium difficile Infection Refractory to Metronidazole and Vancomycin
por: Tannous, George, et al.
Publicado: (2010) -
Serum homocysteine concentration in dogs with immunosuppressant-responsive enteropathy
por: Benvenuti, Elena, et al.
Publicado: (2020)